Abstract
Hypothesis/aims of study. The article is devoted to assessing the effectiveness of intravenous iron preparations in the treatment of anemia in pregnant women. The relevance of improving the treatment of pregnant women with iron deficiency anemia (IDA) is due to an increase in morbidity and adverse effects on the course and outcome of the gestational process, the state of the fetus and newborn. The aim of this comparative study was to assess the efficiency of intravenous and oral iron preparations in pregnant women with IDA.
 Study design, materials and methods. The study included 131 pregnant women. The mean age of the patients was 31.75 (19; 49) years.
 Results. The intravenous preparation of iron carboxymaltosate, after a single administration, has a more pronounced dynamics of hematological and ferrokinetical blood parameters compared to the oral preparation of iron (III) hydroxide polymaltosate after one month of treatment.
 Conclusion. As a result of clinical and laboratory research, the expediency of the use of intravenous iron (III) preparations in the 2nd and 3rd trimester of pregnancy has been substantiated. Iron carboxymaltose exhibits high clinical efficiency, quickly replenishing iron stores in the body. The absence of side effects and ease of use (single administration) allow recommending iron carboxymaltose for the treatment of IDA.
Highlights
The intravenous preparation of iron carboxymaltosate, after a single administration, has a more pronounced dynamics of hematological and ferrokinetical blood parameters compared to the oral preparation of iron (III) hydroxide polymaltosate after one month of treatment
Breymann C, Milman N, Mezzacasa A, et al Ferric carboxymaltose vs oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP)
Summary
The intravenous preparation of iron carboxymaltosate, after a single administration, has a more pronounced dynamics of hematological and ferrokinetical blood parameters compared to the oral preparation of iron (III) hydroxide polymaltosate after one month of treatment
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
